-
1por Kotsiou, Ourania S., Papagiannis, Dimitrios, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Vavougios, George D., Kalantzis, Georgios, Gourgoulianis, Konstantinos I.“...Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. ...”
Publicado 2021
Ligazón do recurso
Ligazón do recurso
Ligazón do recurso
Online Artigo Texto -
2por Kotsiou, Ourania S., Papagiannis, Dimitrios, Fradelos, Evangelos C., Perlepe, Garyfallia, Miziou, Angeliki, Siachpazidou, Dimitra S., Gourgoulianis, Konstantinos I.“...The Rapid Test 2019-nCoV Total Ig, V1210/V1230 (Prognosis Biotech, Greece), and the SARS-CoV-2 IgG II Quant method (Architect, Abbott, Illinois, USA) were used for antibody testing. ...”
Publicado 2021
Ligazón do recurso
Ligazón do recurso
Ligazón do recurso
Online Artigo Texto -
3por Kotsiou, Ourania S., Vavougios, George D., Papagiannis, Dimitrios, Matsiatsiou, Elena, Avgeri, Dimitra, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Gogou, Eudoxia, Kalampokas, Serafim, Kalantzis, Georgios, Kotsios, Vaios S., Gourgoulianis, Konstantinos I.“...Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. ...”
Publicado 2022
Ligazón do recurso
Ligazón do recurso
Ligazón do recurso
Online Artigo Texto -
4por Kotsiou, Ourania S., Karakousis, Nikolaos, Papagiannis, Dimitrios, Matsiatsiou, Elena, Avgeri, Dimitra, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Gogou, Eudoxia, Vavougios, George D., Kalantzis, George, Gourgoulianis, Konstantinos I.“...The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. ...”
Publicado 2022
Ligazón do recurso
Ligazón do recurso
Ligazón do recurso
Online Artigo Texto